Literature DB >> 26613680

Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.

Hidetaka Eguchi1, Kensuke Kumamoto2, Okihide Suzuki3, Masakazu Kohda4, Yuhki Tada4, Yasushi Okazaki4, Hideyuki Ishida3.   

Abstract

Germline deletion of the 3' portion of the Epithelial Cell Adhesion Molecule (EPCAM) gene located 5' upstream of MutS Homolog 2 (MSH2) is a novel mechanism for its inactivation in Lynch syndrome. However, its contribution in Japanese Lynch syndrome patients is poorly understood. Moreover, somatic events inactivating the remaining allele of MSH2 in cancer tissue have not been elucidated in Lynch syndrome patients with such EPCAM deletions. We identified a Japanese Lynch syndrome patient with colon cancer who evidenced germline deletion of a 4130 bp fragment of EPCAM encompassing exons 8 and 9 (c.859-672_*2170del). In normal colonic mucosa, two known fusion-transcripts of EPCAM/MSH2 generated from the rearranged gene were observed and heterozygous methylation of the MSH2 gene promoter was detected. In cancer tissue, dense methylation of MSH2 was observed and MLPA analysis demonstrated somatic deletion of the remaining EPCAM allele including exon 9, indicating that somatic deletion of EPCAM is responsible for complete inactivation of MSH2.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  EPCAM; GI-colorectum-basic; Lynch syndrome; genetics-cancer genetics

Mesh:

Substances:

Year:  2015        PMID: 26613680     DOI: 10.1093/jjco/hyv172

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population.

Authors:  Okihide Suzuki; Hidetaka Eguchi; Noriyasu Chika; Takehiko Sakimoto; Keiichiro Ishibashi; Kensuke Kumamoto; Jun-Ichi Tamaru; Tetsuhiko Tachikawa; Kiwamu Akagi; Tomio Arai; Yasushi Okazaki; Hideyuki Ishida
Journal:  Surg Today       Date:  2017-03-03       Impact factor: 2.549

2.  Germline deletion of chromosome 2p16-21 associated with Lynch syndrome.

Authors:  Soichiro Natsume; Tatsuro Yamaguchi; Hidetaka Eguchi; Yasushi Okazaki; Shin-Ichiro Horiguchi; Hideyuki Ishida
Journal:  Hum Genome Var       Date:  2021-05-19

3.  EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.

Authors:  Sagar J Pathak; James L Mueller; Kevin Okamoto; Barun Das; Jozef Hertecant; Lynn Greenhalgh; Trevor Cole; Vered Pinsk; Baruch Yerushalmi; Odul E Gurkan; Michael Yourshaw; Erick Hernandez; Sandy Oesterreicher; Sandhia Naik; Ian R Sanderson; Irene Axelsson; Daniel Agardh; C Richard Boland; Martin G Martin; Christopher D Putnam; Mamata Sivagnanam
Journal:  Hum Mutat       Date:  2018-11-29       Impact factor: 4.878

4.  Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype.

Authors:  Giulia Cini; Michele Quaia; Vincenzo Canzonieri; Mara Fornasarig; Roberta Maestro; Alberto Morabito; Angela Valentina D'Elia; Emanuele Damiano Urso; Isabella Mammi; Alessandra Viel
Journal:  Mol Genet Genomic Med       Date:  2019-03-27       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.